CJM-112
Product Specifications
Target
Interleukin
Related Pathways
Immunology/Inflammation
Bioactivity
CJM-112 is a humanized monoclonal antibody inhibitor that targets interleukin-17A (IL-17A) . It holds potential for research in inflammatory diseases, such as hidradenitis suppurativa, which involve abnormalities in the IL-17A-related pathway.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
![Rabbit Monoclonal Integrin beta 2/CD18 Antibody (60.3) [DyLight 650]](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
NBP3-12031C 0.1 mL
Rabbit Monoclonal Integrin beta 2/CD18 Antibody (60.3) [DyLight 650]
Sign In for Pricing
View Details 
